Company news

TCGX Acquisition Corp. news in 2026

TCGX Acquisition Corp.'s news releases, calls and decks from 2026, newest first.

TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine

October 19, 2026

TCGX Acquisition Corp. II Announces Pricing of $100,000,000 Initial Public Offering

October 15, 2026

TCGX Acquisition Corp. Announces Completion of its Initial Public Offering

August 6, 2026

Decks in 2026

SPAC Merger (October 2026)
SPAC merger · 31 slides · Oct 19, 2026